Our combination of innovative 3DP technologies and proven, low-risk manufacturing strategies can help you keep existing medicines on the market longer, maximize the potential of your R&D pipeline, and ultimately reach the patients you serve sooner.
Our three-dimensional printing (3DP) platform for pharmaceutical manufacturing is the first and only to be FDA-validated and ready today for commercial-scale drug development.
Using an aqueous fluid to bind together multiple layers of powder, our unique, patent-protected 3DP technology platform can be used to solve some of your toughest product formulation challenges across multiple therapeutic areas.
HIGHER DOSE LOAD WITH FAST DISPERSION
Oral medications can pose administration and/or swallowing challenges for patients in a broad range of disease areas. Our 3DP technology produces a porous, water-soluble precision dose able to disintegrate with a sip of water in less than 10 seconds – a rate previously unachievable for high dose formulations.
NOVEL DOSAGE FORMS AND DELIVERY MODALITIES
Because it does not rely on compression forces, our 3DP Technology is the only delivery platform to date that can achieve high dosage loads (up to 1,000 mg), modified drug release and pre-gastric drug absorption – in an easy to swallow dosage form.
With 3D printed drugs, you can bind multiple layers of powder blend (API and excipients) using an aqueous fluid to produce pre-measured, spill-proof unit-doses designed to rapidly disintegrate in the mouth with just a sip of liquid.
Today, our 3DP for Pharma technology is at the forefront of personalized medicine. Download our white paper to learn how ZipDose Technology is redefining fast melt and opening new opportunities in multiple therapeutic areas.